|
|
|
Clinical Trials at Vermont Cancer Center
Phase II Study of Capecitabine in Patients With Malignant Mesothelioma
|
|
|
Clinical Trials at Vermont Cancer Center
Phase II Study of Capecitabine in Patients With Malignant Mesothelioma